Measles, Mumps and Rubella Combined Vaccine (live-attenuated), Beijing Tiantan Biological Products

麻腮风联合减毒活疫苗（北京天坛生物制品公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles, Mumps and Rubella Combined Vaccine (live-attenuated), Beijing Tiantan Biological Products

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Live attenuated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParotitisRubulavirus InfectionsMeasles

Global Approved IndicationsParotitisRubulavirus InfectionsMeasles

Approved Indications in ChinaParotitisRubulavirus InfectionsMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date2002/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesBeijing Tiantan Biological Products Corporation Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsParotitisRubulavirus InfectionsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD52